Why AI therapists could further isolate vulnerable patients instead of easing suffering

Does the growing popularity of AI therapy herald the rise of the chatbot and the demise of the talking cure?

Nigel Mulligan, Lecturer in Psychotherapy, School of Nursing, Psychotherapy and Community Health, Dublin City University • conversation
April 2, 2025 ~6 min

Feeling political distress? Here are coping strategies a psychologist shares with his clients

Politics in America have become more upsetting than ever for big chunks of the population, but there are ways to cope.

Jeremy P. Shapiro, Adjunct Assistant Professor of Psychological Sciences, Case Western Reserve University • conversation
Jan. 22, 2025 ~8 min


FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face

The FDA’s decision shines a light on some of the unique obstacles that psychedelic drugs may face on the path to approval.

Benjamin Y. Fong, Honors Faculty Fellow, Associate Teaching Professor, and Associate Director of the Center for Work & Democracy, Arizona State University • conversation
Aug. 12, 2024 ~8 min

Psilocybin legislation is helping psychedelic drugs make a comeback – a drug researcher explains the challenges they face

Pharmaceutical giants like Johnson & Johnson as well as smaller startups are investing in psychedelic drug development, and both are pursuing FDA approval for their patented psilocybin formulations.

Benjamin Y. Fong, Drug Researcher and Honors Faculty Fellow, Arizona State University • conversation
Aug. 2, 2024 ~9 min

Navigating mental health treatment options can be overwhelming – a clinical psychologist explains why it’s worth the effort

Knowing which kind of provider to see and how to access help can be half the battle.

Bryan Cochran, Professor of Psychology and Director of Clinical Training, University of Montana • conversation
July 8, 2024 ~10 min

Medication can help you make the most of therapy − a psychologist and neuroscientist explains how

Combining psychotherapy with medication can lead to more immediate and enduring results by boosting the brain’s neuroplasticity.

Rebecca Price, Associate Professor of Psychiatry and Psychology, University of Pittsburgh • conversation
Aug. 28, 2023 ~9 min

Depression too often gets deemed 'hard to treat' when medication falls short

An overreliance on medication as the first-line treatment for depression can lead some people to be labeled with treatment-resistant depression when there are other viable alternatives for relief.

Jay Kayser, PhD Student in Social Work and Developmental Psychology, University of Michigan • conversation
March 15, 2023 ~12 min

Patients suffering with hard-to-treat depression may get relief from noninvasive magnetic brain stimulation

Patients who undergo transcranial magnetic stimulation say it’s painless, with few to no side effects. The treatment isn’t yet widely accessible, but for those who use it, the effects can be profound.

Patricia Junquera, Associate Professor and Vice Chair of Clinical Services, Florida International University • conversation
Nov. 16, 2022 ~7 min


Deep brain stimulation can be life-altering for OCD sufferers when other treatment options fall short

This rare procedure is offered by only a handful of centers in the US and around the world and should be used only when less invasive treatment options for OCD have been tried.

Rachel A. Davis, Associate Professor of Psychiatry and Neurosurgery, University of Colorado Anschutz Medical Campus • conversation
Sept. 28, 2022 ~13 min

Ketamine paired with looking at smiling faces to build positive associations holds promise for helping people with treatment-resistant depression

In a new study, a single infusion of the antidepressant – along with repeated exposure to positive imagery – significantly reduced symptoms in depressed patients in a clinical trial.

Rebecca Price, Associate Professor of Psychiatry and Psychology, University of Pittsburgh Health Sciences • conversation
Sept. 22, 2022 ~6 min

/

3